YOUR FRIENDS' ACTIVITY

    U.S. meningitis deaths rise to 19 as probe of firm intensifies

    * Four more deaths confirmed in past 24 hours

    * FDA agents search offices of firm in Boston

    * Patients continue to contact doctors with symptoms

    BOSTON/WASHINGTON, Oct 17 (Reuters) - The number of deaths

    from a U.S. meningitis outbreak linked to contaminated steroid

    medications rose to 19 on Wednesday, just hours after federal

    agents raided the offices of the company at the center of the

    scandal and took away documents.

    The Centers for Disease Control said states had confirmed

    four more deaths in the last 24 hours as the national outbreak

    grew.

    Two of the deaths were in Tennessee, the hardest hit state

    with eight deaths since the infection was discovered in late

    September. Virginia and Florida each reported one new fatality.

    The daily tally was a reminder that one of the worst U.S.

    health scares in recent years has not been contained, despite

    emergency steps to recall the medications and stop the use of

    products from New England Compounding Center of Massachusetts.

    One of the victims was a 78-year-old man in Marion County,

    Florida, the Florida Department of Health said.

    The number of new cases of meningitis from the injections

    rose by 14 on Wednesday, reaching 245, the CDC said. It said

    there had been another two infections that have not been

    confirmed as meningitis.

    Meningitis is an infection of the membranes covering the

    brain and spinal cord. Fungal meningitis is not contagious.

    The meningitis scare began last month when people began

    arriving at the emergency room of St Thomas hospital in

    Nashville, Tennessee with severe headaches and other symptoms

    after receiving epidural injections for back pain from a

    separate clinic housed in the hospital building.

    The injections were from steroid produced by NECC of

    Massachusetts and shipped to 76 medical facilities in 23 states.

    Health authorities have scrambled to contact nearly 14,000

    patients at risk of meningitis and to remove all the products

    suspected of being contaminated from the shelves.

    But the product was shipped as early as late May and

    patients continue to contact doctors with headaches, fever,

    nausea and stroke-like symptoms. Cases of the disease have been

    confirmed in 15 states and deaths in six.

    OFFICES SEARCHED

    The scare has prompted a host of federal and state

    investigations. On Tuesday evening, U.S. Food and Drug

    Administration agents searched NECC offices in the Boston suburb

    of Framingham and emerged with a large trove of documents.

    NECC is a "compounding" pharmacy, firms that prepare

    specific doses of approved medications, based on guidance from a

    doctor, to meet an individual patient's need. It shipped

    products throughout the United States.

    The Framingham raid came as pressure increased for

    investigators to determine how the product was contaminated and

    who is responsible.

    "If the investigation finds any criminal misdoings, the

    Department of Justice must act decisively, file charges and

    prosecute the company or individuals responsible," said

    Connecticut Democratic Congresswoman Rosa DeLauro, who has

    introduced legislation to give FDA more authority to regulate

    compounding pharmacies.

    A lawyer for NECC said the raid was unnecessary.

    "We have been clear that (NECC) would provide, and has

    provided, anything requested," Paul Cirel, of Collora LLP in

    Boston, said in a statement.

    The FDA, which inspected NECC facilities prior to the raid,

    warned doctors in a conference call on Tuesday that the agency

    could not guarantee the sterility of NECC products. It said

    federal and state health authorities were trying to trace all

    products from NECC around the country.

    A list of more than 131,000 shipping invoices for NECC

    products shipped to medical facilities across the United States

    was sent to state health authorities by the FDA earlier this

    week, the Tennessee Health Department said on its website.

    In Tennessee alone, 74 healthcare facilities received

    shipments from NECC, the state said.

    (Additional reporting by David Bailey, Michael Peltier, David

    Morgan, Ros Krasny, Toni Clarke, Bill Berkrot, Svea

    Herbst-Bayliss, David Morgan and Tim Ghianni; Editing by David

    Brunnstrom)